Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-17-003682)

Filing Details

Accession Number:: 0001179110-17-003682
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-02 17:18:06
Reporting Period:: 2017-02-28

Filing Date:: 2017-03-02
Accepted Time:: 2017-03-02 17:18:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1800	Abbott Laboratories	ABT	Pharmaceutical Preparations (2834)	360698440

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1695686	J Joseph Manning	100 Abbott Park Road Abbott Park IL 60064	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares Without Par Value	Acquisiton	2017-02-28	5,085	$45.46	25,231	No	4	A	Direct
Common Shares Without Par Value	Disposition	2017-02-28	1,463	$45.46	23,768	No	4	F	Direct
Common Shares Without Par Value	Disposition	2017-02-28	387	$44.96	23,381	No	4	S	Direct
Common Shares Without Par Value	Disposition	2017-02-28	56	$44.96	23,325	No	4	S	Direct
Common Shares Without Par Value	Disposition	2017-02-28	300	$44.96	23,025	No	4	S	Direct
Common Shares Without Par Value	Disposition	2017-02-28	1	$44.96	23,024	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.